国泰君安创新医药混合发起C
(021987)公募权益主动型混合型
各季度资产配置
| 季报日期 | 净资总值(亿元) | 净资净值(亿元) | 股票 | 债券 | 现金 | 其他 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | |||
| 2026-06-30 | 0.63 | 0.61 | 0.54 | 86.41% | 86.81% | 0.00 | 0.00% | 0.00% | 0.04 | 6.75% | 6.55% | 0.04 | 6.84% | 6.64% |
| 2026-03-31 | 0.53 | 0.52 | 0.45 | 82.89% | 83.47% | 0.00 | 0.00% | 0.00% | 0.08 | 14.91% | 14.41% | 0.01 | 2.20% | 2.12% |
| 2025-12-31 | 1.09 | 1.08 | 0.70 | 64.00% | 64.38% | 0.00 | 0.00% | 0.00% | 0.39 | 35.94% | 35.56% | 0.00 | 0.06% | 0.06% |
| 2025-09-30 | 1.50 | 1.48 | 1.28 | 84.56% | 84.83% | 0.00 | 0.00% | 0.00% | 0.23 | 15.25% | 14.98% | 0.00 | 0.19% | 0.19% |
| 2025-06-30 | 1.52 | 1.51 | 1.23 | 81.12% | 81.23% | 0.00 | 0.00% | 0.00% | 0.28 | 18.85% | 18.74% | 0.00 | 0.03% | 0.03% |
| 2025-03-31 | 1.79 | 1.73 | 1.49 | 82.53% | 83.13% | 0.00 | 0.00% | 0.00% | 0.28 | 16.03% | 15.47% | 0.03 | 1.44% | 1.40% |
| 2024-12-31 | 2.37 | 2.32 | 1.58 | 66.18% | 66.85% | 0.00 | 0.00% | 0.00% | 0.78 | 33.67% | 33.00% | 0.00 | 0.15% | 0.15% |
| 2024-09-30 | 1.31 | 1.30 | 1.13 | 86.68% | 86.71% | 0.00 | 0.00% | 0.00% | 0.17 | 13.27% | 13.24% | 0.00 | 0.05% | 0.05% |